| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 8e-05 |